RxDoctor Payments Data

Montserrat Camarena-Leija

Goodyear, AZNPI 1952037392

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations.

$3,053in general payments, 2019–2025

Across 132 payments — averaging $23.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$586
  • UCB, Inc.$421
  • AstraZeneca$416
  • Amgen$275
  • Novartis$218
  • Mallinckrodt Hospital Products Inc.$186
  • plus $950 from 10 others

What the payments were for

  • Food & beverage$3,053100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →